Evidence map›Paper›PMID 20237895›Full record

ArticlePlanta2010

Identification of an essential cysteinyl residue for the structure of glutamine synthetase alpha from Phaseolus vulgaris.

Guillermo Estivill, Pilar Guardado, Raymond Buser, Marco Betti, Antonio J Márquez

Abstract read
PubMed Publisher
In one paragraph

Article in Planta, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Guillermo EstivillDepartamento de Bioquímica Vegetal y Biología Molecular, Facultad de Química, Universidad Sevilla, Seville, Spain.
Pilar Guardado
Raymond Buser
Marco Betti
Antonio J Márquez
Universidad de Sevilla · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have studied the possible role, in a plant glutamine synthetase (GS), of the different cysteinyl residues present in this enzyme. For this purpose we carried out the site-directed mutagenesis of the cDNA for alpha-GS polypeptide from Phaseolus vulgaris in the positions corresponding to Cys-92, Cys-159, and Cys-179, followed by heterologous expression in E. coli and enzymatic characterisation of WT and mutant proteins. The results show that neither Cys-92 nor Cys-179 residues were essential for enzyme activity, but the replacement of Cys-159 by alanine or serine strongly affects the quaternary structure and function of the GS enzyme molecule, resulting in a complete loss of enzymatic activity. Other studies using sulfhydryl specific reagents such as pHMB (p-hydroxymercuribenzoate) or DTNB (5,5'-dithiobis-2-nitrobenzoate) confirmed that the profound inhibition produced is associated with an important alteration of the quaternary structure of GS, and suggest that Cys-159 might be the residue responsible for the enzyme inhibition. All these results suggest that the Cys-159 residue is essential for the enzyme structure. The results are also consistent with previous reports based on classical biochemistry studies indicating the presence of essential cysteinyl residues for the enzyme activity of higher plant GS.

Indexed as

Adenosine TriphosphateAmino Acid SequenceBiocatalysisCysteineElectrophoresis, Polyacrylamide GelEnzyme ActivationEscherichia coliGlutamate-Ammonia LigaseMolecular Sequence DataMutagenesis, Site-DirectedMutant ProteinsPhaseolusProtein Structure, SecondaryRecombinant ProteinsSequence AlignmentSequence Analysis, ProteinAdenosine TriphosphateCysteineGlutamate-Ammonia LigaseMutant ProteinsRecombinant ProteinsSulfhydryl Reagents

Identifiers

PMID20237895
OpenAlexW2010015589

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.